While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...

Scientists led by Stephanie Eisenbarth, MD, Ph.D., the Roy and Elaine Patterson Professor of Medicine and director of the ...

This report provides useful evidence that EABR mRNA is at least as effective as standard S mRNA vaccines for the SARS-CoV-2 booster vaccine. Although the methodology and the experimental approaches ...

Aging fundamentally transforms the human genome through accumulative epigenetic modifications—including DNA methylation, ...

Scientists create a vaccine that shields against Crimean-Congo hemorrhagic fever within days and protects for over a year.

ReAlta Life Sciences Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to ...

Researchers at the University of Arizona have uncovered a previously unknown population of circulating immune cells that play ...

Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

Advancements in omics-scale profiling technologies have ushered in new perspectives in immunology research and expanded our ...

In several disease conditions, including infections and cancers, innate immune activation and nutrient scarcity occur together.

Blood proteomics highlights shared and disease-specific immune markers in skin conditions. Learn more about implications for ...